vs
光辉国际（KFY）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
光辉国际的季度营收约是Royalty Pharma plc的1.2倍（$729.8M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 9.9%，领先24.5%），光辉国际同比增速更快（7.0% vs 4.8%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 3.8%）
光辉国际是一家总部位于美国加利福尼亚州洛杉矶的管理咨询企业，成立于1969年。截至2019年，公司在全球53个国家设有111个办事处，员工总数达8198名，旗下设有咨询、数字化、高管寻访、招聘流程外包及专业人才寻访四大业务板块，为全球客户提供全方位的人力资源及管理解决方案。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
KFY vs RPRX — 直观对比
营收规模更大
KFY
是对方的1.2倍
$622.0M
营收增速更快
KFY
高出2.2%
4.8%
净利率更高
RPRX
高出24.5%
9.9%
两年增速更快
RPRX
近两年复合增速
3.8%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $729.8M | $622.0M |
| 净利润 | $72.4M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 13.5% | 62.4% |
| 净利率 | 9.9% | 34.4% |
| 营收同比 | 7.0% | 4.8% |
| 净利润同比 | 19.1% | 2.9% |
| 每股收益（稀释后） | $1.36 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KFYRPRX
| Q4 25 | $729.8M | $622.0M | ||
| Q3 25 | $715.5M | $609.3M | ||
| Q2 25 | $719.8M | $578.7M | ||
| Q1 25 | $676.5M | $568.2M | ||
| Q4 24 | $682.0M | $593.6M | ||
| Q3 24 | $682.8M | $564.7M | ||
| Q2 24 | $699.9M | $537.3M | ||
| Q1 24 | $676.9M | $568.0M |
净利润KFYRPRX
| Q4 25 | $72.4M | $214.2M | ||
| Q3 25 | $66.6M | $288.2M | ||
| Q2 25 | $64.2M | $30.2M | ||
| Q1 25 | $58.4M | $238.3M | ||
| Q4 24 | $60.8M | $208.2M | ||
| Q3 24 | $62.6M | $544.0M | ||
| Q2 24 | $65.2M | $102.0M | ||
| Q1 24 | $59.1M | $4.8M |
营业利润率KFYRPRX
| Q4 25 | 13.5% | 62.4% | ||
| Q3 25 | 11.7% | 70.1% | ||
| Q2 25 | 14.5% | 36.3% | ||
| Q1 25 | 11.6% | 94.0% | ||
| Q4 24 | 12.8% | 60.9% | ||
| Q3 24 | 11.1% | — | ||
| Q2 24 | 11.9% | 50.2% | ||
| Q1 24 | 7.4% | -13.0% |
净利率KFYRPRX
| Q4 25 | 9.9% | 34.4% | ||
| Q3 25 | 9.3% | 47.3% | ||
| Q2 25 | 8.9% | 5.2% | ||
| Q1 25 | 8.6% | 41.9% | ||
| Q4 24 | 8.9% | 35.1% | ||
| Q3 24 | 9.2% | 96.3% | ||
| Q2 24 | 9.3% | 19.0% | ||
| Q1 24 | 8.7% | 0.8% |
每股收益（稀释后）KFYRPRX
| Q4 25 | $1.36 | $0.49 | ||
| Q3 25 | $1.26 | $0.67 | ||
| Q2 25 | $1.19 | $0.07 | ||
| Q1 25 | $1.10 | $0.55 | ||
| Q4 24 | $1.14 | $0.46 | ||
| Q3 24 | $1.17 | $1.21 | ||
| Q2 24 | $1.25 | $0.23 | ||
| Q1 24 | $1.13 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $801.1M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $1.9B | $9.7B |
| 总资产 | $3.7B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资KFYRPRX
| Q4 25 | $801.1M | $618.7M | ||
| Q3 25 | $721.1M | $938.9M | ||
| Q2 25 | $1.0B | $631.9M | ||
| Q1 25 | $820.0M | $1.1B | ||
| Q4 24 | $735.5M | $929.0M | ||
| Q3 24 | $674.0M | $950.1M | ||
| Q2 24 | $983.7M | $1.8B | ||
| Q1 24 | $782.5M | $843.0M |
总债务KFYRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益KFYRPRX
| Q4 25 | $1.9B | $9.7B | ||
| Q3 25 | $1.9B | $9.6B | ||
| Q2 25 | $1.9B | $9.5B | ||
| Q1 25 | $1.8B | $9.8B | ||
| Q4 24 | $1.8B | $10.3B | ||
| Q3 24 | $1.8B | $10.3B | ||
| Q2 24 | $1.7B | $9.8B | ||
| Q1 24 | $1.7B | $9.9B |
总资产KFYRPRX
| Q4 25 | $3.7B | $19.6B | ||
| Q3 25 | $3.6B | $19.3B | ||
| Q2 25 | $3.9B | $18.3B | ||
| Q1 25 | $3.6B | $17.6B | ||
| Q4 24 | $3.5B | $18.2B | ||
| Q3 24 | $3.4B | $18.0B | ||
| Q2 24 | $3.7B | $17.7B | ||
| Q1 24 | $3.6B | $16.1B |
负债/权益比KFYRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $121.4M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $100.7M | — |
| 自由现金流率自由现金流/营收 | 13.8% | — |
| 资本支出强度资本支出/营收 | 2.8% | — |
| 现金转化率经营现金流/净利润 | 1.68× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $272.6M | — |
8季度趋势，按日历期对齐
经营现金流KFYRPRX
| Q4 25 | $121.4M | $827.1M | ||
| Q3 25 | $-237.4M | $702.6M | ||
| Q2 25 | $255.8M | $364.0M | ||
| Q1 25 | $213.7M | $596.1M | ||
| Q4 24 | $122.0M | $742.5M | ||
| Q3 24 | $-227.2M | $703.6M | ||
| Q2 24 | $261.9M | $658.2M | ||
| Q1 24 | $164.0M | $664.6M |
自由现金流KFYRPRX
| Q4 25 | $100.7M | — | ||
| Q3 25 | $-260.0M | — | ||
| Q2 25 | $235.5M | — | ||
| Q1 25 | $196.4M | — | ||
| Q4 24 | $107.7M | — | ||
| Q3 24 | $-237.7M | — | ||
| Q2 24 | $250.0M | — | ||
| Q1 24 | $152.3M | — |
自由现金流率KFYRPRX
| Q4 25 | 13.8% | — | ||
| Q3 25 | -36.3% | — | ||
| Q2 25 | 32.7% | — | ||
| Q1 25 | 29.0% | — | ||
| Q4 24 | 15.8% | — | ||
| Q3 24 | -34.8% | — | ||
| Q2 24 | 35.7% | — | ||
| Q1 24 | 22.5% | — |
资本支出强度KFYRPRX
| Q4 25 | 2.8% | — | ||
| Q3 25 | 3.2% | — | ||
| Q2 25 | 2.8% | — | ||
| Q1 25 | 2.6% | — | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 1.7% | — |
现金转化率KFYRPRX
| Q4 25 | 1.68× | 3.86× | ||
| Q3 25 | -3.56× | 2.44× | ||
| Q2 25 | 3.98× | 12.06× | ||
| Q1 25 | 3.66× | 2.50× | ||
| Q4 24 | 2.01× | 3.57× | ||
| Q3 24 | -3.63× | 1.29× | ||
| Q2 24 | 4.02× | 6.45× | ||
| Q1 24 | 2.78× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KFY
| Industrial | $234.0M | 32% |
| Technology Service | $104.5M | 14% |
| RPO | $92.3M | 13% |
| Digital | $91.2M | 13% |
| Consumer Goods | $85.0M | 12% |
| Executive Search EMEA | $52.2M | 7% |
| Education Non Profit And General | $43.2M | 6% |
| Executive Search Asia Pacific | $24.3M | 3% |
| Reimbursed Out Of Pocket Engagement Expenses | $8.1M | 1% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
